Comparison of parental and CDKi-resistant ovarian cancer cell lines
收藏官方服务：
资源简介：
Comparison of parental and CDKi-resistant ovarian cancer cell lines
应用场景：
创建时间：
2014-11-22
相关数据集
Additional file 1 of High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
Additional file 1: Supplementary Table 1. DEGs_of_4_datasets.
NIAID Data Ecosystem70
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models
Ovarian cancers are still largely treated with platinum-based chemotherapy as the standard of care, yet few biomarkers of clinical response have had an impact on clinical decision making as of yet. Tw
NIAID Data Ecosystem20
The molecular landscape of homologous recombination deficient, end-stage, high grade serous ovarian cancer
High grade serous ovarian cancer (HGSC) is frequently characterized by homologous recombination (HR) DNA repair deficiency, and while most such tumors are sensitive to initial treatment, acquired resi
NIAID Data Ecosystem20
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1)
Collagen type XI alpha 1 (COL11A1) is identified as one of the most upregulated genes in cisplatin-resistant ovarian cancer and recurrent ovarian cancer. However, the exact functions of COL11A1 in cis
NIAID Data Ecosystem30
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy. FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem20
